The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)-2-(3-bromo-4,5-dihydroisoxazol-5-yl)ethanone ID: ALA4756558
PubChem CID: 162655559
Max Phase: Preclinical
Molecular Formula: C22H22BrCl2N3O2
Molecular Weight: 511.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CC1CC(Br)=NO1)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C22H22BrCl2N3O2/c23-20-13-19(30-26-20)14-21(29)27-9-11-28(12-10-27)22(15-1-5-17(24)6-2-15)16-3-7-18(25)8-4-16/h1-8,19,22H,9-14H2
Standard InChI Key: HQQUMBOYFMQLMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
17.2721 -26.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8575 -25.4211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8575 -26.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2740 -24.7084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8600 -23.9939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0341 -23.9934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6238 -24.7134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0360 -25.4252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0334 -26.8485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6230 -27.5627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0335 -28.2788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8628 -28.2762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2736 -27.5613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6227 -23.2789 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.6240 -28.9903 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.0972 -26.1362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5076 -26.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5076 -25.4211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3327 -25.4211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7473 -26.1362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5723 -26.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3327 -26.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9828 -25.4211 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9828 -26.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8037 -26.8533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2881 -27.5160 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0694 -27.2644 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0715 -26.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2914 -26.1879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7368 -25.9625 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 2 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
6 14 1 0
11 15 1 0
1 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
17 22 1 0
19 20 1 0
20 21 1 0
20 22 1 0
21 23 2 0
21 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 25 1 0
28 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 511.25Molecular Weight (Monoisotopic): 509.0272AlogP: 5.11#Rotatable Bonds: 5Polar Surface Area: 45.14Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 5.58CX LogP: 4.76CX LogD: 4.76Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: -1.05
References 1. Eaton JK,Furst L,Cai LL,Viswanathan VS,Schreiber SL. (2020) Structure-activity relationships of GPX4 inhibitor warheads., 30 (23.0): [PMID:32920142 ] [10.1016/j.bmcl.2020.127538 ]